Molinaro A, Braadland PR, Carpino G, Carreras A, Nikolaidis M, Hanzely P, Beck KR, Ali AH, Bossen L, Frank A, Lundqvist A, Juran BD, Overi D, Geng L, Amundsen-Isaksen E, Reims HM, Björk I, Grzyb K, Abildgaard A, Folseraas T, Cornillet M, Helgadóttir H, McCauley BM, Cristoferi L, Carbone M, Cardinale V, Høivik ML, Engesæter LK, Tjønnfjord SKV, McCann Aet al.(2026) Gut microbiota-derived imidazole propionate promotes primary sclerosing cholangitis via p38 signalling Nat Metab(in press) DOI 10.1038/s42255-026-01600-1, PubMed 42698000
Iversen PO, Holm K, Bang C, Tjønnfjord GE, Gedde-Dahl T, Ali MM, Hov JR(2026) Extracorporeal photopheresis as GVHD prophylaxis: No impact on gut microbiota-a randomized controlled trial Br J Haematol(in press) DOI 10.1111/bjh.70831, PubMed 42687407
Maseng MG, Hansen SH, Grännö O, Bang C, Lund C, Huppertz-Hauss G, Perminow G, Valeur J, Bengtson MB, Opheim R, Boyar R, Frigstad SO, Aabrekk TB, Detlie TE, Kristensen VA, Strande V, Hovde Ø, Asak Ø, Franke A, Halfvarsson J, Høivik ML, Hov JR(2026) Disentangling the gut microbiome and inflammation in inflammatory bowel diseases: longitudinal observations from the IBSEN III study Inflamm Bowel Dis, 32(9), 1695-1706 DOI 10.1093/ibd/izag051, PubMed 41966990
